Perspectives on Enquiry & Evidence
Reflections on the RCT DUPLICATE Study and Increasing Confidence in Real-World Evidence
Randomized clinical trials (RCTs) have long been considered the gold standard for assessing the efficacy of medical treatments, but real-world evidence (RWE) is often more representative of routine clinical care. The RCT DUPLICATE study makes great strides in comparing the two, but the study has its limitations: notably, the lack of quantitative bias analysis.
Estimator Choice in Synthetic Control Arm Analyses
Interview with Grammati Sarri on Moderating an Issue Panel 2022
Optimizing Human-Machine Partnership for Up-To-Date Evidence
An Interview with Gabriel Tremblay on his Poster Contributions to ISPOR US 2022
Bayesian Statistics and Its Applications: New Webinar by Professor Yuan Ji
Join Cytel’s HEOR Consultants at ISPOR US 2022
Career Perspectives: Interview with Charles Warne, Associate Director of Biostatistics
How can an optimized data strategy support your clinical program?
Subscribe to our weekly newsletter
By submitting you agree to Cytel’s Privacy Notice